False
Research, trends, news, and views
September 23, 2025
TruSight™ Oncology 500 v2 (TSO500v2) is an updated next-generation sequencing (NGS) assay designed to enable laboratories with in-house comprehensive genomic profiling (CGP) from formalin-fixed, paraffin-embedded (FFPE) tissue samples...
12:00 pm - 1:00 pm GMT-4 min read
September 18, 2025
By Helen Bristow
With millions of contextualized patient data records now available across oncology, clinical development needs to evolve for the precision medicine era, says Gen Li
6 min read
September 15, 2025
By Kathryn Wighton
New workflow is developed for spatiotemporal lipidomics to classify gliomas and monitor treatment response
1 min read
September 12, 2025
By Kathryn Wighton
An analysis of breast cancer cases found human epidermal growth factor receptor-2 messenger RNA scores correlated with immunohistochemistry but did not replace standard testing
1 min read
September 12, 2025
By Kathryn Wighton
Researchers identified a biomarker panel predicting amyotrophic lateral sclerosis onset
1 min read
September 9, 2025
How a single-cell proteomics test, run on a standard pathology slide, can reshape treatment decisions
4 min read
September 4, 2025
A new method employs nanobodies for high-speed immunolabeling of thick brain tissue
2 min read
September 2, 2025
By Jessica Allerton
Updates aim to improve clarity and consistency in pathology reporting amid growing demands from clinical oncology
6 min read
August 26, 2025
By Dariusz Borys
Perhaps so-called modern diseases aren’t as new as we thought...
3 min read
August 22, 2025
By Helen Bristow
What does the future of bladder cancer monitoring look like? Recent research offers some clues...
3 min read
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
False